Monday, January 30th, 2006 - Alfacell Revises Guidance on Patient Enrollment for the ONCONASE Confirmatory Phase IIIb Clinical Trial in Unresectable Malignant Mesothelioma
Archive for January, 2006
Friday, January 27th, 2006 - Alfacell Forms New Thoracic Cancer Advisory Board
Thursday, January 26th, 2006 - Virginia Businessman Receives Jail Sentence For Using False Asbestos Training Certificates to Obtain Contracts For Removal Jobs in Public Buildings
Thursday, January 19th, 2006 - Alfacell Provides Update on ONCONASE Clinical Program
Tuesday, January 17th, 2006 - Survivor of Experimental Treatment for Rare Cancer Uses Apple’s iPod to Podcast Hope to Other
Thursday, January 12th, 2006 - INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic From Memorial Sloan-Kettering Cancer Center
Wednesday, January 11th, 2006 - Air Data From New Orleans and Mississippi Released
Monday, January 9th, 2006 - Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
Tuesday, January 3rd, 2006 - Morphotek Expands Oncology Pipeline With Product Candidate From the National Cancer Institute (NCI)
